{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:46Z","timestamp":1794048886741,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC0901502"],"award-info":[{"award-number":["2016YFC0901502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Municipal Science and Technology Project","award":["Z151100003915126"],"award-info":[{"award-number":["Z151100003915126"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570061"],"award-info":[{"award-number":["81570061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0775-9","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T02:47:53Z","timestamp":1519094873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study"],"prefix":"10.1186","volume":"13","author":[{"given":"Yongzhong","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7662-531X","authenticated-orcid":false,"given":"Kai-Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"775_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.anndiagpath.2015.06.003","volume":"19","author":"K Thway","year":"2015","unstructured":"Thway K, Fisher C. PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol. 2015;19:359\u201368.","journal-title":"Ann Diagn Pathol"},{"key":"775_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1378\/chest.14-3095","volume":"148","author":"AS Kristof","year":"2015","unstructured":"Kristof AS, Li PZ, Major P, Landry JS. Lymphangioleiomyomatosis and tuberous sclerosis complex in Quebec: prevalence and health-care utilization. Chest. 2015;148:444\u20139.","journal-title":"Chest"},{"key":"775_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/qjmed\/hcr116","volume":"104","author":"EC Harknett","year":"2011","unstructured":"Harknett EC, Chang WYC, Byrnes S, Johnson J, Lazor R, Cohen MM, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011;104:971\u20139.","journal-title":"QJM"},{"key":"775_CR4","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","volume":"126","author":"AM Taveira-DaSilva","year":"2004","unstructured":"Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J. Decline in lung function in patients with Lymphangioleiomyomatosis treated with or without progesterone. Chest. 2004;126:1867\u201374.","journal-title":"Chest"},{"key":"775_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364:1595\u2013606.","journal-title":"N Engl J Med"},{"key":"775_CR6","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.rmed.2010.03.017","volume":"104","author":"CG Glasgow","year":"2010","unstructured":"Glasgow CG, Steagall WK, Taveira-Dasilva A, Pacheco-Rodriguez G, Cai X, El-Chemaly S, et al. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med. 2010;104:S45\u201358.","journal-title":"Respir Med"},{"key":"775_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376.","journal-title":"Cell"},{"key":"775_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","volume":"190","author":"J Yao","year":"2014","unstructured":"Yao J, Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. Am J Respir Crit Care Med American Thoracic Society. 2014;190:1273\u201382.","journal-title":"Am J Respir Crit Care Med American Thoracic Society"},{"key":"775_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.resinv.2013.03.002","volume":"51","author":"K Ando","year":"2013","unstructured":"Ando K, Kurihara M, Kataoka H, Ueyama M, Togo S, Sato T, et al. Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis. Respir Investig. 2013;51:175\u201383.","journal-title":"Respir Investig"},{"key":"775_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","volume":"154","author":"AM Taveira-DaSilva","year":"2011","unstructured":"Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med. 2011;154:797\u2013805.","journal-title":"Ann Intern Med"},{"issue":"1","key":"775_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chest.2017.05.012","volume":"153","author":"AM Taveira-DaSilva","year":"2018","unstructured":"Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J. Long-term effect of sirolimus on serum VEGF-D levels in patients with lymphangioleiomyomatosis. Chest. 2018;153(1):124\u201332.","journal-title":"Chest"},{"key":"775_CR12","first-page":"97","volume":"48","author":"A Hecimovic","year":"2015","unstructured":"Hecimovic A, Jakopovic M, Pavlisa G, Jankovic M, Vukic-Dugac A, Redzepi G, et al. Successful treatment of pulmonary and lymphatic manifestations of lymphangioleiomyomatosis with sirolimus. Lymphology. 2015;48:97\u2013102.","journal-title":"Lymphology"},{"key":"775_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1590\/S1806-37132015000004553","volume":"41","author":"CSG Freitas","year":"2015","unstructured":"Freitas CSG, Baldi BG, Ara\u00fajo MS, Heiden GI, Kairalla RA, Carvalho CRR. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations. J Bras Pneumol. 2015;41:275\u201380.","journal-title":"J Bras Pneumol"},{"key":"775_CR14","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, et al. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res American Association for Cancer Research. 2011;17:4071\u201381.","journal-title":"Clin Cancer Res American Association for Cancer Research"},{"key":"775_CR15","first-page":"14","volume":"35","author":"SR Johnson","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. European respiratory. Society. 2010;35:14\u201326.","journal-title":"Society"},{"key":"775_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. European respiratory Society. 2005;26:511\u201322.","journal-title":"Eur. Respir. J. European respiratory Society"},{"key":"775_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. American Thoracic Society. 2002;166:111\u20137.","journal-title":"Am. J. Respir. Crit. Care Med. American Thoracic Society"},{"key":"775_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","volume":"85","author":"PW Jones","year":"1991","unstructured":"Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. 1991;85:25\u201331.","journal-title":"Respir Med"},{"key":"775_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","volume":"365","author":"J Vestbo","year":"2011","unstructured":"Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365:1184\u201392.","journal-title":"N Engl J Med"},{"key":"775_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","volume":"194","author":"FX McCormack","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, Young LR, AM T-DS, Glasgow CG, et al. Official American Thoracic Society\/Japanese respiratory society clinical practice guidelines: Lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016;194:748\u201361.","journal-title":"Am J Respir Crit Care Med"},{"key":"775_CR21","first-page":"66","volume":"12","author":"C Neurohr","year":"2011","unstructured":"Neurohr C, Hoffmann AL, Huppmann P, Herrera VA, Ihle F, Leuschner S, et al. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis? Respir Res BioMed Central. 2011;12:66.","journal-title":"Respir Res BioMed Central"},{"key":"775_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1001-9294(10)60038-7","volume":"25","author":"K-F Xu","year":"2010","unstructured":"Xu K-F, Wang L, Tian X-L, Gui Y-S, Peng M, Cai B-Q, et al. The St. George's respiratory questionnaire in Lymphangioleiomyomatosis. Chin Med Sci J. 2010;25:140\u20135.","journal-title":"Chin Med Sci J"},{"issue":"6","key":"775_CR23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1378\/chest.12-0161","volume":"143","author":"JJ Swigris","year":"2013","unstructured":"Swigris JJ, Lee H-S, Cohen M, Inoue Y, Moss J, Singer LG, et al. St. George's respiratory questionnaire has longitudinal construct validity in Lymphangioleiomyomatosis. Chest. 2013;143(6):1671\u20138.","journal-title":"Chest"},{"key":"775_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1513\/AnnalsATS.201212-125OC","volume":"10","author":"P Barrera","year":"2013","unstructured":"Barrera P, Simons SO, Luijk B, Wessels MJC, Heijdra YF. Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis. Ann Am Thorac Soc. American Thoracic Society. 2013;10:408\u20139.","journal-title":"Ann Am Thorac Soc. American Thoracic Society"},{"key":"775_CR25","first-page":"53","volume":"45","author":"A Chachaj","year":"2012","unstructured":"Chachaj A, Drozdz K, Chabowski M, Dziegiel P, Grzegorek I, Wojnar A, et al. Chyloperitoneum, chylothorax and lower extremity lymphedema in woman with sporadic lymphangioleiomyomatosis successfully treated with sirolimus: a case report. Lymphology. 2012;45:53\u20137.","journal-title":"Lymphology"},{"key":"775_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/rcr2.105","volume":"3","author":"CM Ellender","year":"2015","unstructured":"Ellender CM, Williams TJ, Gooi J, Snell GI, Whitford HM. Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis. Respirol Case Rep. 2015;3:72\u20134.","journal-title":"Respirol Case Rep"},{"key":"775_CR27","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.athoracsur.2008.07.062","volume":"86","author":"T Ohara","year":"2008","unstructured":"Ohara T, Oto T, Miyoshi K, Tao H, Yamane M, Toyooka S, et al. Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. Ann Thorac Surg. 2008;86:e7\u20138.","journal-title":"Ann Thorac Surg"},{"key":"775_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1155\/2013\/120376","volume":"20","author":"D Rozenberg","year":"2013","unstructured":"Rozenberg D, Thenganatt J. Dramatic response to sirolimus in lymphangioleiomyomatosis. Can Respir J Hindawi Publishing Corporation. 2013;20:413\u20134.","journal-title":"Can Respir J Hindawi Publishing Corporation"},{"key":"775_CR29","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1513\/AnnalsATS.201605-335OC","volume":"13","author":"T Takada","year":"2016","unstructured":"Takada T, Mikami A, Kitamura N, Seyama K, Inoue Y, Nagai K, et al. Efficacy and safety of long-term Sirolimus therapy for Asian patients with Lymphangioleiomyomatosis. Ann Am Thorac Soc American Thoracic Society. 2016;13:1912\u201322.","journal-title":"Ann Am Thorac Soc American Thoracic Society"},{"key":"775_CR30","first-page":"1","volume":"0","author":"J Bee","year":"2017","unstructured":"Bee J, Fuller S, Miller S, Johnson SR. Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study. Thorax. 2017;0:1\u20137.","journal-title":"Thorax"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T15:13:45Z","timestamp":1660490025000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0775-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was part of the LAM registry study of PUMCH. The protocol was approved by the Ethical Committee of Peking Union Medical College Hospital (S-379). All subjects included in this study signed informed consent documents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"34"}}